All news

dsm-firmenich raises 2026 sales growth outlook to around 5% from 2-4%

dsm-firmenich · · AI-summarised by FinFlash

dsm-firmenich lifted its 2026 like-for-like sales growth forecast to around 5% from 2-4% after third-quarter sales rose to 2,368 million euros from 2,238 million. Adjusted EBITDA reached 482 million euros, up 8% on a like-for-like basis, with the margin at 20.4% against 20.5% a year earlier. The Dutch-Swiss ingredients group kept its margin outlook at around 20% and completed a 540 million euro buyback on September 30.

So What?

Upgrade is positive for European consumer ingredient names; flat margins mean investors will focus on volume-led growth quality.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.